Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Launched by ZYDOLAB - INSTITUTE OF CYTOLOGY AND IMMUNE CYTOCHEMISTRY · Aug 11, 2015

Keywords

ClinConnect Summary

This clinical trial is comparing two different methods for treating a condition called condyloma acuminata, which are growths caused by the human papillomavirus (HPV). The two treatments being studied are carbon dioxide laser ablation and electrocoagulation (a technique that uses heat to remove tissue). The trial involves 114 women and aims to find out which method provides better cosmetic results, as judged by the patients themselves six weeks after treatment. Other important factors being looked at include how long the procedure takes, any complications that might arise, how satisfied patients are, the level of pain after the procedure, and whether the growths come back.

To participate in the trial, women aged between 65 and 74 who have condyloma acuminata may be eligible. They need to provide informed consent and should not have any significant language barriers, be pregnant, or have certain medical conditions like blood clotting disorders or active infections. Participants can expect to undergo one of the treatments, and their experiences will be monitored to help researchers understand which method is more effective and safer. This trial is currently recruiting participants, and it is an opportunity to help improve treatment options for this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • informed consent
• • women with anogenital affection of condyloma acuminata
• Exclusion Criteria:
• • significant language barrier
• • pregnancy
• • unwillingness to participate
• • the use of blood thinner or known coagulation disorder
• • the use of immunosuppressive medicament
• • HIV-Infection
• • malignant diseases
• • local therapy within 8 weeks before Treatment
• • wound healing disorder